Till startsida
University of Gothenburg
Sitemap
To content Read more about how we use cookies on gu.se

LENA WALLIN

GNC SWEDEN

PROFILE

Lena Wallin is a specialist doctor in child and adolescent psychiatry. She works at the CAP Special Unit at the Sahlgrenska University Hospital, where she takes part in interdisciplinary assessment and treatment of children and adolescents with bipolar or psychotic syndromes, obsessive-compulsive and related syndromes, tics/Tourette’s syndrome and selective mutism. Lena was scientific reviewer in the preparations for the national guidelines for pharmacological treatment of obsessive-compulsive disorder in children and adolescents, at the National Board on Health and Welfares. Together with a group of experts she participated in writing treatment recommendations for the Medical Product Agency, ”Neuroleptics in certain child psychiatric conditions for children and adolescents” and ”Depression, anxiety and obsessive-compulsive disorder in children and adolescents". Lena has also taken part in writing the review version of the Swedish Child Psychiatry Association’s ”National guidelines for anxiety and obsessive-compulsive syndromes”. As of September 2016, Lena is a part-time PhD student at the GNC, at the department for neuroscience and physiology. Her PhD project is titled “Mental health in 22Q11-deletion syndrome from childhood to adult: a prospective longitudinal study of 90 individuals”. In 2007, psychologist Lena Niklasson published a thesis on assessment of neuropsychological and neuropsychiatric evaluations of 100 individuals with 22q11ds. This is a follow-up study with the aim of assessing cognitive, behavioural, neuropsychiatric and psychiatric disabilities in these individuals. We also aim to evaluate development of symptoms over time and quality of life. In the first study, the diagnosis 22q11ds was confirmed through FISH-analysis. New genetic analyses and analysis of plasma amino acids will be performed to elucidate potential correlations between cognitive, psychiatric and neuropsychiatric symptoms, disabilities and these biological markers. This might increase the possibility of early diagnosis and treatment, thus improving the chances for better long-term outcome.

Photo: Fotograf Cecilia
 

Contact Information

Lena Wallin

Page Manager: Anna Spyrou|Last update: 6/28/2018
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?